Vicarious Surgical Inc. (RBOT)
NYSE: RBOT · Real-Time Price · USD
4.550
-0.030 (-0.66%)
Nov 6, 2025, 10:30 AM EST - Market open
Vicarious Surgical Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Vicarious Surgical stock has a target of 7.00, which predicts a 53.85% increase from the current stock price of 4.55.
Price Target: $7.00 (+53.85%)
Analyst Consensus: Hold
* Price targets were last updated on Aug 13, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Vicarious Surgical is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $8.5 → $7 | Hold | Maintains | $8.5 → $7 | +53.85% | Aug 13, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $11 → $8.5 | Hold | Maintains | $11 → $8.5 | +86.81% | Mar 18, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $12 → $11 | Hold | Maintains | $12 → $11 | +130.77% | Nov 13, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $30 → $12 | Hold | Maintains | $30 → $12 | +163.74% | Aug 13, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $18 → $10 | Hold | Maintains | $18 → $10 | +119.78% | Jul 15, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-9.24
from -10.74
EPS Next Year
-6.60
from -9.24
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -8.58 | -4.03 | |
| Avg | -9.24 | -6.60 | |
| Low | -9.36 | -9.72 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.